The Diagnostics Equity Consortium (DEC), an initiative by the Pan-African Treatment Access Movement (PATAM) and the O’Neill Institute for National and Global Health Law, aims to create a unified advocacy agenda tailored to diverse country-specific needs surrounding diagnostics access, particularly enhancing diagnostic capabilities in sub-Saharan Africa.
In the first part of the “Combating Antimicrobial Resistance (AMR) with Advanced Diagnostics” webinar series, participants learned how advanced diagnostics can combat AMR and discover effective advocacy strategies.
Speakers:
- Tapiwanashe Kujinga, Director, Pan-African Treatment Access Movement
- Gunturu Revathi, Head of Clinical Microbiology, Aga Khan University Hospital
Moderated by: Alice Kayongo, Senior Associate, Center for Global Health Policy and Politics, O’Neill Institute